Runben Biotechnology
SHSE:603193
HK$ 21,16
+ HK$0,32 (1,54%)
21,16 HK$
+HK$0,32 (1,54%)
End-of-day quote: 03/27/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

HK$0,76
Earnings Per Share
HK$3,47
Revenue Per Share
58,03%
Gross Margin %
HK$8,43 B
Market Cap
HK$0,00 B
Long-Term Debt
Earnings Per Share
HK$0,76
Revenue Per Share
HK$3,47
Gross Margin %
58,03%
Market Cap
HK$8,43 B
Long-Term Debt
HK$0,00 B

Financials

Year Year 2024 2023 2022
EPS Earnings Per Share HK$0,74 HK$0,64 HK$0,47
Earnings Earnings HK$299,40M HK$0,00M HK$0,00M
RPS Revenue Per Share HK$3,47 N/A N/A
Revenue Revenue HK$1,40B HK$0,00M HK$0,00M
OCF Operating Cash Flow HK$273,75M HK$0,00M HK$0,00M
FCF Free Cash Flow HK$0,00M HK$0,00M HK$0,00M
OM Operating Margin 23,38% 23,49% 20,71%
GM % Gross Margin % 58,03% 56,11% 54,06%
FCFS Free Cash Flow Per Share HK$0,48 HK$0,68 HK$0,37
LT Debt Long-Term Debt N/A N/A N/A
Sha. Stocks 404,59M 404,59M 0M
×